-
1
-
-
59349098805
-
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report
-
Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-MorTeale H.F., Futterweit W. et al.: "The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report". Fertil. Steril., 2009, 91, 456.
-
(2009)
Fertil. Steril.
, vol.91
, pp. 456
-
-
Azziz, R.1
Carmina, E.2
Dewailly, D.3
Diamanti-Kandarakis, E.4
Escobar-MorTeale, H.F.5
Futterweit, W.6
-
2
-
-
34447299467
-
Endothelial progenitor cell dysfunction: Mechanisms and therapeutic approaches
-
Bauersachs J., Thum T.: "Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches". Eur. J. Clin. Invest., 2007, 37, 603.
-
(2007)
Eur. J. Clin. Invest.
, vol.37
, pp. 603
-
-
Bauersachs, J.1
Thum, T.2
-
3
-
-
0018906734
-
Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease
-
Burghen G.A., Givens J.R., Kitabchi A.E.: "Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease". J. Clin. Endocrinol. Metab., 1980, 50, 113.
-
(1980)
J. Clin. Endocrinol. Metab.
, vol.50
, pp. 113
-
-
Burghen, G.A.1
Givens, J.R.2
Kitabchi, A.E.3
-
4
-
-
0036283724
-
Insulin resistance, polycycstic ovary syndrome, and type 2 diabetes mellitus
-
Ovalle F., Azziz R.: "Insulin resistance, polycycstic ovary syndrome, and type 2 diabetes mellitus". Fertil. Steril., 2002, 77, 1095.
-
(2002)
Fertil. Steril.
, vol.77
, pp. 1095
-
-
Ovalle, F.1
Azziz, R.2
-
5
-
-
15944390236
-
Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin resistant women with polycystic ovary syndrome
-
Ortega-González C., Luna S., Hernández L., Crespo G., Aguayo P., Arteaga-Troncoso G. et al.: "Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin resistant women with polycystic ovary syndrome". J. Clin. Endocrinol. Metab., 2005, 90, 1360.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 1360
-
-
Ortega-González, C.1
Luna, S.2
Hernández, L.3
Crespo, G.4
Aguayo, P.5
Arteaga-Troncoso, G.6
-
6
-
-
1442301080
-
Inflammatory markers and risk of developing type 2 diabetes in women
-
Hu F.B., Meigs J.B., Li T.Y., Rifai N., Manson J.E.: "Inflammatory markers and risk of developing type 2 diabetes in women". Diabetes, 2004, 53, 693.
-
(2004)
Diabetes
, vol.53
, pp. 693
-
-
Hu, F.B.1
Meigs, J.B.2
Li, T.Y.3
Rifai, N.4
Manson, J.E.5
-
7
-
-
0442307969
-
IkappaB kinases: Key regulators of the NF-κB pathway
-
Yamamoto Y., Gaynor R.B.: "IkappaB kinases: key regulators of the NF-κB pathway". Trends Biochem. Sci., 2004, 29, 72.
-
(2004)
Trends Biochem. Sci.
, vol.29
, pp. 72
-
-
Yamamoto, Y.1
Gaynor, R.B.2
-
8
-
-
2342532378
-
The polycystic ovary syndrome perse is not associated with increased chronic inflammation
-
Möhlig M., Spranger J., Osterhoff M., Ristow M., Pfeiffer A.F., Schill T. et al.: "The polycystic ovary syndrome perse is not associated with increased chronic inflammation". Eur. J. Endocrinol., 2004, 150, 525.
-
(2004)
Eur. J. Endocrinol.
, vol.150
, pp. 525
-
-
Möhlig, M.1
Spranger, J.2
Osterhoff, M.3
Ristow, M.4
Pfeiffer, A.F.5
Schill, T.6
-
9
-
-
0346186090
-
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
-
The Rotterdam ESHRE /ASRM-sponsored PCOS consensus workshop group
-
The Rotterdam ESHRE /ASRM-sponsored PCOS consensus workshop group.: "Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)". Hum. Reprod., 2004, 19, 41.
-
(2004)
Hum. Reprod.
, vol.19
, pp. 41
-
-
-
10
-
-
38449088275
-
Exploration of the classification of polycystic ovarian syndrome
-
Lin J.F., Li X., Zhu M.W.: "Exploration of the classification of polycystic ovarian syndrome". Chin. J. Obstet. Gynecol., 2006, 10, 684.
-
(2006)
Chin. J. Obstet. Gynecol.
, vol.10
, pp. 684
-
-
Lin, J.F.1
Li, X.2
Zhu, M.W.3
-
11
-
-
34548771778
-
Polycystic ovary syndrome and its developmental origins
-
Dumesic D.A., Abbott D.H., Padmanabhan V.: "Polycystic ovary syndrome and its developmental origins" Rev. Endocr. Metab. Disord., 2007, 8, 127.
-
(2007)
Rev. Endocr. Metab. Disord.
, vol.8
, pp. 127
-
-
Dumesic, D.A.1
Abbott, D.H.2
Padmanabhan, V.3
-
13
-
-
33645324444
-
Risk of T2DM and impaired fasting glucose among PCOS subjects: Results of an 8-year follow-up
-
Boudreaux M.Y., Talbott E.O., Kip K.E., Brooks M.M., Witchel S.F.: "Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up". Curr. Diab Rep., 2006, 6, 77.
-
(2006)
Curr. Diab Rep.
, vol.6
, pp. 77
-
-
Boudreaux, M.Y.1
Talbott, E.O.2
Kip, K.E.3
Brooks, M.M.4
Witchel, S.F.5
-
14
-
-
84902515205
-
Two armor biguanides treat the PCOS clinical observation
-
Liu H.Y.: "Two armor biguanides treat the PCOS clinical observation". Health for Everybody, 2008, 5, 27.
-
(2008)
Health for Everybody
, vol.5
, pp. 27
-
-
Liu, H.Y.1
-
15
-
-
70349408589
-
Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
-
Pasquali R., Gambineri A.: "Targeting insulin sensitivity in the treatment of polycystic ovary syndrome". Expert Opin. Ther. Targets, 2009, 13, 1205.
-
(2009)
Expert Opin. Ther. Targets
, vol.13
, pp. 1205
-
-
Pasquali, R.1
Gambineri, A.2
-
16
-
-
5144220551
-
Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity
-
Baillargeon J.P., Jakubowicz D.J., Iuorno M.J., Jakubowicz S., Nestler J.E.: "Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity". Fertil. Steril., 2004, 82, 893.
-
(2004)
Fertil. Steril.
, vol.82
, pp. 893
-
-
Baillargeon, J.P.1
Jakubowicz, D.J.2
Iuorno, M.J.3
Jakubowicz, S.4
Nestler, J.E.5
-
17
-
-
33847401515
-
Genetic variation, C-reactive protein levels, and incidence of diabetes
-
Dehghan A., Kardys I., de Maat M.P., Uitterlinden A.G., Sijbrands E.J., Bootsma A.H. et al.: "Genetic variation, C-reactive protein levels, and incidence of diabetes". Diabetes, 2007, 56, 872.
-
(2007)
Diabetes
, vol.56
, pp. 872
-
-
Dehghan, A.1
Kardys, I.2
De Maat, M.P.3
Uitterlinden, A.G.4
Sijbrands, E.J.5
Bootsma, A.H.6
-
18
-
-
60149088617
-
Critical appraisal of CRP measurement for the prediction of coronary heart diease events: New data and systematic review of 31 prospective cohorts
-
Shah T., Casas J.P., Cooper J.A., Tzoulaki I., Sofat R., McCormack V. et al.: "Critical appraisal of CRP measurement for the prediction of coronary heart diease events: new data and systematic review of 31 prospective cohorts", lnt J. Epidemiol., 2009, 38, 217.
-
(2009)
Lnt J. Epidemiol.
, vol.38
, pp. 217
-
-
Shah, T.1
Casas, J.P.2
Cooper, J.A.3
Tzoulaki, I.4
Sofat, R.5
McCormack, V.6
-
19
-
-
29844439694
-
Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases
-
Ruggeri R.M., Barresi G., Sciacchitano S., Trimarchi F., Benvenga S., Trovato M.: "Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases". Histol. Histopathol., 2006, 21, 249.
-
(2006)
Histol. Histopathol.
, vol.21
, pp. 249
-
-
Ruggeri, R.M.1
Barresi, G.2
Sciacchitano, S.3
Trimarchi, F.4
Benvenga, S.5
Trovato, M.6
-
20
-
-
33845350615
-
Autoimmune thyroid Diseases
-
Caturegli P., Kimura H., Rocchi R., Rose N.R.: "Autoimmune thyroid Diseases". Curr. Opin. Rheumatol., 2007, 19, 44.
-
(2007)
Curr. Opin. Rheumatol.
, vol.19
, pp. 44
-
-
Caturegli, P.1
Kimura, H.2
Rocchi, R.3
Rose, N.R.4
-
21
-
-
2442434415
-
Increased C-reactive protein levels in the polycystic ovary syndrome: A marker of cardiovascular disease
-
Boumlan N., Levy Y., Leiba R., Shachar S., Linn R., Zinder O. et al.: "Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease". J. Clin. Endorinol. Metab., 2004, 89, 2160.
-
(2004)
J. Clin. Endorinol. Metab.
, vol.89
, pp. 2160
-
-
Boumlan, N.1
Levy, Y.2
Leiba, R.3
Shachar, S.4
Linn, R.5
Zinder, O.6
|